Back to home
MANE logo

Is MANE (Veradermics, Incorporated) Halal or Haram?

New York Stock ExchangeHealthcareBiotechnology$3.42B2026-04-27
MANE is Halal4/4 screens passed

Veradermics easily passes all AAOIFI Shariah screens, making it a fully compliant biotechnology investment. The company operates with a pristine balance sheet, carrying 0.0% debt to market cap and holding just 1.6% in cash and interest-bearing securities. Furthermore, it derives zero interest income, ensuring its revenues remain perfectly aligned with Islamic financial standards.

Price Chart (5D)

$90.41-13.39 (-12.90%)
2026-06-082026-06-01

MANE — Last 7 Days

DateOpenHighLowCloseVolumeChange
2026-06-0893.7996.9890.1890.32426K-3.70%
2026-06-05100.12101.8290.3691.69549K-8.42%
2026-06-0497.17103.2595.90101.23440K+4.18%
2026-06-0397.5697.9895.0096.74579K-0.84%
2026-06-02101.51104.0497.6198.18428K-3.28%
2026-06-01101.40105.0099.00101.51510K+0.11%
2026-05-29105.07105.5094.52100.911.2M-3.96%

Discussion

Sign in to join the discussion

Loading comments...

Shariah Screening Details for MANE

Business Activity

Permissible

Veradermics passes the business activity screen because developing therapeutics like VDPHL01 for dermatologic conditions and hair loss is a permissible, life-enhancing medical activity under Islamic principles.

Debt / Market Cap

0.00%

Debt: $0Threshold: ≤33%

Interest Income

0.00%

Interest: $481,000Threshold: ≤5%

Cash & Securities

1.55%

Cash: $53.1MThreshold: ≤33%

About Veradermics, Incorporated (MANE)

Veradermics, Incorporated is a biopharmaceutical company specializing in novel therapeutics for dermatologic and aesthetic conditions. Its pipeline features targeted treatments like VDPHL01, an oral, non-hormonal therapy for chronic hair loss, alongside microarray patch technologies for common warts and alopecia.

For Muslim investors utilizing HalalStocks.co.uk, Veradermics represents a fully Halal investment opportunity within the healthcare sector. The company successfully passed all four AAOIFI screening criteria, meaning its core medical operations and financial structures align strictly with Islamic principles.

From an Islamic finance perspective, the company boasts an exceptionally clean balance sheet with a 0.0% debt-to-market capitalization ratio. Additionally, its interest income stands at 0.00% and cash reserves sit at a minimal 1.6%, eliminating concerns regarding riba-generating assets or impermissible liquidity.

Since there is no major scholarly debate regarding its core biotechnology operations, investors can hold this stock with confidence. However, shareholders should continue to monitor future clinical trial funding mechanisms to ensure the company does not take on conventional debt as its pipeline scales.

CEO

Reid Waldman

Employees

21

IPO Date

2026-02-04

Headquarters

New Haven, CT, US

MANE Key Financial Statistics

Revenue

$0

Net Income

$-26.5M

EPS (Diluted)

$-0.14

Stock Price

91.66

Beta

52-Week Range

32-101.81

Total Debt

$0

Total Equity

$54.7M

Current Ratio

11.77

MANE Financial Health & Profitability

Profit Margins

Gross Margin0.0%
Operating Margin0.0%
Net Margin0.0%

Net Cash

$53.1M

Cash: $53.1M — Debt: $0

R&D Spending

$23.3M

% of Revenue

0%

Frequently Asked Questions About MANE

Is MANE (Veradermics, Incorporated) stock halal to invest in?
Based on our AAOIFI-standard shariah screening, MANE is Halal and considered permissible for Muslim investors. It passed all 4 of 4 compliance screens including business activity review, debt-to-market-cap ratio (0.00% vs ≤33% threshold), interest income ratio (0.00% vs ≤5% threshold), and cash & securities ratio (1.55% vs ≤33% threshold).
What does Veradermics, Incorporated do?
Veradermics, Incorporated is a biopharmaceutical company specializing in novel therapeutics for dermatologic and aesthetic conditions. Its pipeline features targeted treatments like VDPHL01, an oral, non-hormonal therapy for chronic hair loss, alongside microarray patch technologies for common warts and alopecia. For Muslim investors utilizing HalalStocks.co.uk, Veradermics represents a fully Halal investment opportunity within the healthcare sector. The company successfully passed all four AAOIFI screening criteria, meaning its core medical operations and financial structures align strictly with Islamic principles. From an Islamic finance perspective, the company boasts an exceptionally clean balance sheet with a 0.0% debt-to-market capitalization ratio. Additionally, its interest income stands at 0.00% and cash reserves sit at a minimal 1.6%, eliminating concerns regarding riba-generating assets or impermissible liquidity. Since there is no major scholarly debate regarding its core biotechnology operations, investors can hold this stock with confidence. However, shareholders should continue to monitor future clinical trial funding mechanisms to ensure the company does not take on conventional debt as its pipeline scales. Veradermics, Incorporated operates in the Healthcare sector under the Biotechnology industry and is headquartered in New Haven, CT, US. The company is led by CEO Reid Waldman and employs approximately 21 people.
What screening criteria were used for MANE?
MANE was screened using AAOIFI-based shariah compliance criteria. Four tests are applied: (1) Business Activity — the company's core business must not derive primary income from haram (prohibited) activities such as alcohol, gambling, tobacco, or interest-based finance. (2) Debt-to-Market-Cap — total debt must not exceed 33% of market capitalization. (3) Interest Income — interest income must not exceed 5% of total revenue. (4) Cash & Securities — cash and interest-bearing securities must not exceed 33% of market cap. MANE passed 4 of these 4 screens.
Does MANE require income purification?
Although MANE passes all shariah screens, it does earn $481,000 in interest income (0.00% of revenue). Many scholars recommend purifying this portion by donating the equivalent percentage of any dividends received to charity. For example, if you receive $100 in dividends, you would donate approximately $0.00 to purify the income.
When was MANE last screened?
MANE was last screened on 2026-04-27. Shariah compliance status can change as companies report new financial data, acquire new businesses, or shift revenue streams. We recommend checking back periodically for the most up-to-date screening results.

Disclaimer

This shariah compliance assessment for MANE (Veradermics, Incorporated) is provided for informational purposes only and does not constitute financial, investment, or religious advice. Screening criteria are based on widely accepted AAOIFI standards, but individual scholars may differ in their opinions. Always consult with a qualified Islamic scholar and licensed financial advisor before making investment decisions. Past screening status does not guarantee future compliance. Last screened: 2026-04-27.

Other Halal Stocks in Healthcare